The identification of NATs for multiple AD-associated genes, including APP, BACE2, and APH1A, in addition to MAPT, highlights the potential role of antisense transcripts in modulating the expression of genes involved in AD pathogenesis [34]. The gene discussed is BACE2; the disease is Alzheimer disease.